NL-OMON22185
Suspended
Not Applicable
The RAINBOW study: Rheumatoid Arthritis ImplemeNtation of Biological dose Optimization in real World
This is an investigator-initiated study, funded by the Sint Maartenskliniek0 sites320 target enrollmentTBD
ConditionsRheumatoid Arthritis (RA)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis (RA)
- Sponsor
- This is an investigator-initiated study, funded by the Sint Maartenskliniek
- Enrollment
- 320
- Status
- Suspended
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Rheumatoid arthritis (clinical diagnosis of treating rheumatologist, fulfilled at any time point between start of the disease and inclusion) operationalized by DOT diagnosis 101\.
- •Being treated in a center in which the RAINBOW implementation project is starting
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Refractory Rheumatoid ArthritisM05Seropositive rheumatoid arthritisDRKS00005807Abteilung für RheumatologieMedizinische Universität Wien219
Active, not recruiting
Phase 1
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014886agasaki University Hospital250
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014881agasaki University Hospital250
Recruiting
Not Applicable
Rheumatoid Arthritis Patients rePort Onset Reactivatioarthritisrheumatoid arthritis10023213NL-OMON30946Erasmus MC, Universitair Medisch Centrum Rotterdam150